Tikun Olam-Cannbit Pharmaceuticals Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
TKUN
IL0010843675
Pharmaceuticals
Sales 2022 | 49.3 180.83 3.89K | Sales 2023 | 44.23 162.24 3.49K | Capitalization | 25.49M 93.5M 2.01B |
---|---|---|---|---|---|
Net income 2022 | -48M -176M -3.78B | Net income 2023 | -88M -323M -6.94B | EV / Sales 2022 | 1,234,605 x |
Net Debt 2022 | 17.5M 64.2M 1.38B | Net Debt 2023 | 13.42M 49.22M 1.06B | EV / Sales 2023 | 879,698 x |
P/E ratio 2022 |
-0.97
x | P/E ratio 2023 |
-0.22
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 66.64% |
Managers | Title | Age | Since |
---|---|---|---|
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Erez Navon
BRD | Director/Board Member | 50 | - |
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Yaron Razon
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
+41.20% | 4.24B | |
+136.64% | 2.23B | |
+153.97% | 84.17M |